Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup
Clinical trial NCT02858193 · COMPLETED
Trial details
- NCT number
- NCT02858193
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-04
- Primary completion
- 2016-07-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.